Latest Articles

Publication Date
Indications and Efficacy of Progestogen-Monotherapy as Menopause Hormone Therapy: A Narrative Review.

Menopausal hormone therapy (MHT) remains the most effective treatment for vasomotor symptoms (VMS) and other manifestations of menopause; however, its use is limited in women with contraindications to oestrogen. Progestogen …

Published: June 25, 2026, midnight
Diagnostic Performance of Saline/Gel Sonovaginography in Assessment of Deep Infiltrating Endometriosis at Posterior Compartments; A Systematic Review and Meta-Analysis.

Sonovaginography (SVG) is a specialized ultrasound technique for evaluating certain locations of deep endometriosis (DE) in the posterior compartments. In this study, we assessed the diagnostic accuracy of saline/gel SVG …

Published: June 25, 2026, midnight
Salivary miRNAs in the diagnosis of endometriosis An invited narrative scientific literature review, commissioned by European Board and College of Obstetrics and Gynaecology (EBCOG).

Endometriosis is a common gynaecological condition, the diagnosis of which has been made for many years through invasive procedures, such as laparoscopy. In recent years, non-invasive methods have been proposed, …

Published: June 25, 2026, midnight
Correction: Endometrioid cancer associated with endometriosis: from the seed and soil theory to clinical practice.

[This corrects the article DOI: 10.3389/fonc.2022.859510.].

Published: June 25, 2026, midnight
Catamenial Pneumothorax as an Underrecognized Manifestation of Thoracic Endometriosis: A 25-Year Single-Center Experience.

Objectives: Catamenial pneumothorax (CP) is a rare but clinically relevant cause of spontaneous pneumothorax (SP) in women and is associated with high recurrence rates. We hypothesized that CP is underrecognized …

Published: June 25, 2026, midnight
Biopharma bites: Remix's reverse merger, Absci's raise, ADC's layoffs, and a new R&D head for Lundbeck - FirstWord PHARMA

Biopharma bites: Remix's reverse merger, Absci's raise, ADC's layoffs, and a new R&D head for Lundbeck FirstWord PHARMA

Published: June 24, 2026, 11:14 p.m.
Xella Health Emerges from Stealth to Give Women Answers the Healthcare System Hasn’t - MedCity News

Xella Health Emerges from Stealth to Give Women Answers the Healthcare System Hasn’t MedCity News

Published: June 24, 2026, 10:10 p.m.
Exclusive BAC Article: Absci Corporation; Positive Phase 1 Data ABS-201 AGA, Interim And Final POC Data 2nd Half 2026/Early 2027, Respectively, Advancement Endometriosis And Catalysts (NASDAQ:ABSI) - Seeking Alpha

Exclusive BAC Article: Absci Corporation; Positive Phase 1 Data ABS-201 AGA, Interim And Final POC Data 2nd Half 2026/Early 2027, Respectively, Advancement Endometriosis And Catalysts (NASDAQ:ABSI) Seeking Alpha

Published: June 24, 2026, 7:18 p.m.
Hair Relaxer Lawsuit Settlement | June 2026 Litigation Update - Lawsuit Information Center

Hair Relaxer Lawsuit Settlement | June 2026 Litigation Update Lawsuit Information Center

Published: June 24, 2026, 5:50 p.m.
The best DIM supplements - wddty.com

The best DIM supplements wddty.com

Published: June 24, 2026, 4:49 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!